Skip to main content
. 2017 Oct 27;8(63):106948–106961. doi: 10.18632/oncotarget.22157

Figure 1. Spectrum of mutations in the 84 patients with myelodysplastic syndrome (MDS) (where each row represents a single patient).

Figure 1

Only 28 genes are shown, the remainder of genes analyzed did not present mutations in this cohort of patients (SF1, VHL, KDM6A, PTEN, HRAS, and EPOR). Yellow (group 1): total number of mutations per patient ≤2 and at least ≥1 mutation per patient in DNA methylation pathway; Green (group 2): total number of mutations per patient ≤2, and 0 mutations per patient in DNA methylation genes; Blue (group 3): total number of mutations per patient >2 and at least ≥1 mutation per patient in DNA methylation pathway; and Red (group 4): total number of mutations per patient >2, and 0 mutations per patient in DNA methylation pathway.